Response to Letter to the Editor from Madhuri Tribhuvan and Shashikant N. Phatke.

Creator(s)

• Kevin V. Tobin
• Addison Leabo
• J Steven Leeder, Children's Mercy HospitalFollow
• Joga Gobburu
• Allison Dunn

Document Type

Letter to the Editor

Publication Date

6-2026

Identifier

DOI: 10.1002/jcph.70212

Abstract

Comment on “Understanding Atomoxetine Exposure Variability in Children and Adolescents with ADHD through Population Pharmacokinetics” 

Madhuri Tribhuvan MS, Shashikant N. Phatke BDS Volume 66Issue 6The Journal of Clinical Pharmacology
First Published online: May 29, 2026

Journal Title

Journal of clinical pharmacology

Volume

66

Issue

6

First Page

70212

Last Page

70212

PubMed ID

42212531

Comments

Grants and funding

• Eunice Kennedy Shriver National Institute of Child Health and Human Development

Recommended Citation

Tobin KV, Leabo A, Leeder JS, Gobburu J, Dunn A. Response to Letter to the Editor from Madhuri Tribhuvan and Shashikant N. Phatke. J Clin Pharmacol. 2026;66(6):e70212. doi:10.1002/jcph.70212